Arm, Qualcomm Face Off In Court: What To Expect From Silicon Soap Opera
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 16 2024
0mins
Should l Buy ARM?
Source: Benzinga
Legal Dispute Overview: Arm Holdings is in a legal battle with Qualcomm over intellectual property rights related to Qualcomm's acquisition of NUVIA, which includes licensing agreements that Arm claims need renegotiation.
Industry Impact and Predictions: The outcome of the case could significantly affect the tech industry, as both companies are expected to settle, potentially resulting in Qualcomm paying more for access to Arm's technology.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ARM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ARM
Wall Street analysts forecast ARM stock price to rise
24 Analyst Rating
19 Buy
4 Hold
1 Sell
Strong Buy
Current: 134.960
Low
120.00
Averages
160.58
High
201.00
Current: 134.960
Low
120.00
Averages
160.58
High
201.00
About ARM
Arm Holdings plc is engaged in operating a global computing platform. It architects, develops, and licenses high-performance and energy-efficient Arm compute platforms. The Company’s principal operations and activities are the licensing, marketing, research and development of central processing unit (CPU) design intellectual property (IP), graphics processors, system IP, market optimized platform IP, and associated software, tools and other related services. Its complementary products include GPU and NPU accelerators, interconnect, and others. Its primary product offerings are CPU products that address diverse performance, power, and cost requirements. It offers a family of GPU and NPU products providing efficient computing acceleration and an optimal visual experience across a wide range of devices. Its CPU, GPU, and System IP products integrated into a foundational compute platform optimized for a specific end market.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- First Data Center CPU Launch: Arm introduces the Arm AGI CPU, its first data center CPU designed for AI, delivering over 2x performance compared to x86 platforms, marking the company's entry into production silicon products and expected to accelerate AI infrastructure development.
- Partner Support: Developed in collaboration with leading partners like Meta, the Arm AGI CPU is backed by strong support from the global ecosystem, anticipating over 4x growth in CPU demand for data centers to meet the rising AI workload.
- Performance and Scalability: The Arm AGI CPU supports up to 136 Arm Neoverse V3 cores per CPU with a 300-watt TDP, providing deterministic performance under sustained loads, significantly enhancing workload density and computational efficiency in data centers.
- Ecosystem Expansion: Supported by over 50 leading companies, including AWS, Google, and NVIDIA, the launch of the Arm AGI CPU solidifies Arm's strategic position in AI infrastructure, driving future technological innovations.
See More

- New Product Launch: Arm Holdings unveiled new data center-focused CPUs, resulting in a 16.5% stock price increase, now trading near $156.50, indicating strong market demand for its latest chip designs and solidifying its position in the AI and cloud infrastructure markets.
- Sales Outlook Upgrade: The company raised its sales outlook, reflecting sustained demand for its products, which not only boosts investor confidence but may also attract more capital inflows, driving future revenue growth.
- ETF Influence Expansion: The surge in Arm's stock price also lifted 85 exchange-traded funds (ETFs) that hold its shares, collectively owning approximately 7.8 million shares, highlighting Arm's growing significance in passive investment vehicles.
- Concentration Investment Effect: ETFs with the highest allocations to Arm will benefit the most from this stock price increase, underscoring how concentrated positioning in key semiconductor companies can amplify gains across technology-focused portfolios.
See More
- Leadership Change: ON Holding has appointed co-founders David Allemann and Caspar Coppetti as co-CEOs effective May 1, aiming to address disappointing sales forecasts that led to a stock price drop, with market concerns about whether this founder-led transition can maintain the innovative edge.
- Executive Overhaul: The leadership shakeup extends beyond the CEO role, with a new CFO and COO also set to take over in May as part of a comprehensive operational reset, intended to enhance management efficiency and market competitiveness.
- Premium Market Strategy: The new co-CEOs are focusing on selective high-margin product franchises, aiming to maintain the brand's
See More
- Oil Price Impact: Oil prices have dropped below $90 per barrel due to hopes for a truce between the U.S. and Iran, which could positively influence the stock market, as falling oil prices generally lead to a more favorable outlook for equities despite Iran's denial of ceasefire intentions.
- Surge in Arm Chip Demand: Arm's first in-house designed AGI CPU chip has seen incredible demand, with projections of $15 billion in revenue by 2031, prompting Raymond James to upgrade its stock rating from hold to buy, resulting in a 12% increase in share price, aligning with Nvidia's GPU performance.
- OpenAI Fundraising Milestone: OpenAI has raised an additional $10 billion from investors, bringing its total fundraising in this round to over $120 billion, with significant participation from institutions like Microsoft, indicating strong market confidence in its future growth potential.
- Merck's Strategic Acquisition: Merck is acquiring cancer biotech Terns Pharmaceuticals for $6.7 billion to bolster its oncology portfolio ahead of the 2028 patent expiration of its top-selling drug Keytruda, highlighting Merck's strategic focus on cancer treatment advancements.
See More
Company Overview: ARM Holdings PLC is a prominent technology company known for its semiconductor and software design.
Target Price Increase: Susquehanna has raised the target price for ARM Holdings from $150 to $170, indicating a positive outlook on the company's performance.
See More
- New Product Launch: Arm Holdings has introduced its AGI CPU focused on data centers, projecting annual revenue of $25 billion by 2031, which represents over sixfold growth from 2025, indicating strong market potential and long-term profitability.
- Market Share Growth: Arm aims to capture approximately 15% of the $100 billion total addressable market for server CPUs, with revenue expectations of $1 billion in fiscal years 2027 and 2028, showcasing its competitiveness in the rapidly growing AI computing sector.
- Technical Advantages: The new CPU features 136 cores, offering 6 GB/s memory bandwidth per core with a power consumption of around 300 watts, catering to clients like Meta and OpenAI seeking low-power computing solutions, thereby solidifying Arm's position in efficient computing.
- Positive Industry Response: Analysts are generally optimistic about Arm's strategic shift, believing that its AGI CPU will become the best choice for AI workloads, with expectations of rapid adoption by hyperscalers, driving continued stock price appreciation.
See More











